Conformational diversity and ligand tunnels of mammalian cytochrome P450s

The mammalian cytochrome P450 (CYP) enzymes play important roles in drug metabolism, steroid biosynthesis, and xenobiotic degradation. The active site of CYPs is buried in the protein and thus the ligands have to enter and exit the active site via ligand tunnels. Conformational changes of flexible parts of the protein usually accompany the entrance and exit of ligands. Comparison of the crystal structures of mammalian CYPs in closed, open, and partially open states reveals that the greatest conformational diversity associated with ligand tunnel opening is in the regions of the B–C and F–G loops. Some CYPs have been observed to adopt different open and closed conformations when bound to different ligands, suggesting that the ligand entrance and exit routes might differ according to the ligand properties. Mammalian CYPs are mostly membrane‐bound enzymes, making them difficult to characterize structurally and dynamically. A range of molecular dynamics simulation techniques has been applied to investigate the dynamics and the ligand tunnels of these proteins both in the aqueous environment, and more recently, in lipid bilayers. These simulations not only reveal multiple tunnels through which ligands can pass but also show that different tunnels are preferred by different ligands and that the lipid bilayer can influence the protein dynamics and tunnel opening. The results indicate that not only the active site but also the ligand tunnels can contribute to the different substrate specificity profiles of the mammalian CYPs.

[1]  C David Stout,et al.  Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. , 2003, Biochemistry.

[2]  J. Halpert,et al.  Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel . , 2010, Biochemistry.

[3]  C David Stout,et al.  Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.

[4]  C. Chiang,et al.  Structures of Prostacyclin Synthase and Its Complexes with Substrate Analog and Inhibitor Reveal a Ligand-specific Heme Conformation Change* , 2008, Journal of Biological Chemistry.

[5]  Rebecca C Wade,et al.  Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9. , 2012, Current drug metabolism.

[6]  Danielson Pb,et al.  The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. , 2002 .

[7]  J. Halpert,et al.  Investigation by site‐directed mutagenesis of the role of cytochrome P450 2B4 non‐active‐site residues in protein–ligand interactions based on crystal structures of the ligand‐bound enzyme , 2012, The FEBS journal.

[8]  Eric F. Johnson,et al.  Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.

[9]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[10]  K. Battaile,et al.  Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode* , 2010, The Journal of Biological Chemistry.

[11]  Virgil L. Woods,et al.  Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity. , 2011, Biochemistry.

[12]  Weiliang Zhu,et al.  Possible Pathway(s) of Metyrapone Egress from the Active Site of Cytochrome P450 3A4: A Molecular Dynamics Simulation , 2007, Drug Metabolism and Disposition.

[13]  Rebecca C Wade,et al.  The ins and outs of cytochrome P450s. , 2007, Biochimica et biophysica acta.

[14]  S. D. Black Membrane topology of the mammalian P450 cytochromes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  S D Black,et al.  Membrane topology of liver microsomal cytochrome P450 2B4 determined via monoclonal antibodies directed to the halt-transfer signal. , 1994, Biochemistry.

[16]  James R. Halpert,et al.  Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole , 2006, Journal of Biological Chemistry.

[17]  Sundarapandian Thangapandian,et al.  Probing possible egress channels for multiple ligands in human CYP3A4: A molecular modeling study , 2010, Journal of molecular modeling.

[18]  C. Stout,et al.  Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain* , 2010, The Journal of Biological Chemistry.

[19]  M. Wilce,et al.  The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. , 2003, Biochimica et biophysica acta.

[20]  Mark S. P. Sansom,et al.  Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9 , 2011, PLoS Comput. Biol..

[21]  Karl-Heinz Ott,et al.  Parametrization of GROMOS force field for oligosaccharides and assessment of efficiency of molecular dynamics simulations , 1996, J. Comput. Chem..

[22]  Eric F. Johnson,et al.  Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1* , 2010, The Journal of Biological Chemistry.

[23]  Frank E. Blaney,et al.  Crystal Structure of Human Cytochrome P450 2D6* , 2005, Journal of Biological Chemistry.

[24]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[25]  E. Scott,et al.  Nicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Binding and Access Channel in Human Cytochrome P450 2A6 and 2A13 Enzymes* , 2012, The Journal of Biological Chemistry.

[26]  W. Pryor Cytochrome P450: Structure, mechanism, and biochemistry , 1996 .

[27]  W. Pangborn,et al.  Structural basis for androgen specificity and oestrogen synthesis in human aromatase , 2009, Nature.

[28]  Eric F. Johnson,et al.  The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.

[29]  F. Mackenzie,et al.  Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system , 2011, Proceedings of the National Academy of Sciences.

[30]  R C Wade,et al.  How do substrates enter and products exit the buried active site of cytochrome P450cam? 2. Steered molecular dynamics and adiabatic mapping of substrate pathways. , 2000, Journal of molecular biology.

[31]  C David Stout,et al.  Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen , 2005, Nature Structural &Molecular Biology.

[32]  F. Guengerich,et al.  Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid via Acetaldehyde* , 1999, The Journal of Biological Chemistry.

[33]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[34]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[35]  Rebecca C Wade,et al.  Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? , 2005, EMBO reports.

[36]  D E McRee,et al.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.

[37]  Sugunadevi Sakkiah,et al.  Molecular modeling study on orphan human protein CYP4A22 for identification of potential ligand binding site. , 2010, Journal of molecular graphics & modelling.

[38]  Karel Berka,et al.  Membrane Position of Ibuprofen Agrees with Suggested Access Path Entrance to Cytochrome P450 2C9 Active Site , 2011, The journal of physical chemistry. A.

[39]  M. Machius,et al.  Pivotal role of water in the mechanism of P450BM-3. , 2001, Biochemistry.

[40]  C David Stout,et al.  Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding. , 2003, Biochemistry.

[41]  Weihua Li,et al.  POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION , 2005, Drug Metabolism and Disposition.

[42]  S. Sligar,et al.  Structural differences between soluble and membrane bound cytochrome P450s. , 2012, Journal of inorganic biochemistry.

[43]  J. Halpert,et al.  Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning. , 2009, Biochemistry.

[44]  E. Scott,et al.  CYTOCHROME P450 17A1 STRUCTURES WITH PROSTATE CANCER DRUGS ABIRATERONE AND TOK-001 , 2011, Nature.

[45]  E. Scott,et al.  Key Residues Controlling Phenacetin Metabolism by Human Cytochrome P450 2A Enzymes , 2008, Drug Metabolism and Disposition.

[46]  C David Stout,et al.  Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.

[47]  Feixiong Cheng,et al.  Investigation of Indazole Unbinding Pathways in CYP2E1 by Molecular Dynamics Simulations , 2012, PloS one.

[48]  B. K. Muralidhara,et al.  Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4. , 2007, Biochemistry.

[49]  James R. Halpert,et al.  An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Poulos,et al.  Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir , 2010, Proceedings of the National Academy of Sciences.

[51]  E. Scott,et al.  Structures of Human Cytochrome P-450 2E1 , 2008, Journal of Biological Chemistry.

[52]  Eric F. Johnson,et al.  Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound* , 2012, The Journal of Biological Chemistry.

[53]  Virgil L. Woods,et al.  Plasticity of Cytochrome P450 2B4 as Investigated by Hydrogen-Deuterium Exchange Mass Spectrometry and X-ray Crystallography* , 2010, The Journal of Biological Chemistry.

[54]  J. Halpert,et al.  Structures of Cytochrome P450 2B6 Bound to 4-Benzylpyridine and 4-(4-Nitrobenzyl)pyridine: Insight into Inhibitor Binding and Rearrangement of Active Site Side Chains , 2011, Molecular Pharmacology.

[55]  R. Wade,et al.  How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms. , 2000, Journal of molecular biology.

[56]  Ruth Nussinov,et al.  Theoretical Characterization of Substrate Access/Exit Channels in the Human Cytochrome P450 3A4 Enzyme: Involvement of Phenylalanine Residues in the Gating Mechanism , 2009, The journal of physical chemistry. B.

[57]  Weihua Li,et al.  Exploring coumarin egress channels in human cytochrome p450 2a6 by random acceleration and steered molecular dynamics simulations , 2011, Proteins.

[58]  Michal Otyepka,et al.  Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. , 2008, The journal of physical chemistry. B.

[59]  T. Poulos,et al.  Interaction of human cytochrome P4503A4 with ritonavir analogs. , 2012, Archives of biochemistry and biophysics.

[60]  Tao Zhang,et al.  Long-Range Effects of a Peripheral Mutation on the Enzymatic Activity of Cytochrome P450 1A2 , 2011, J. Chem. Inf. Model..

[61]  Karel Berka,et al.  Dynamics and hydration of the active sites of mammalian cytochromes P450 probed by molecular dynamics simulations. , 2012, Current drug metabolism.

[62]  Stephanie C Huelga,et al.  Crystal Structure of a Cytochrome P450 2B6 Genetic Variant in Complex with the Inhibitor 4-(4-Chlorophenyl)imidazole at 2.0-Å Resolution , 2010, Molecular Pharmacology.

[63]  Eric F. Johnson,et al.  Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. , 2007, Archives of biochemistry and biophysics.

[64]  K. Battaile,et al.  Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine , 2012, The FEBS journal.

[65]  T. Strassner,et al.  Modeling of Selforganizing Systems , 1997 .

[66]  Xiaodong Zhang,et al.  Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. , 2006, Journal of medicinal chemistry.

[67]  M Ingelman-Sundberg,et al.  Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. , 2001, Mutation research.

[68]  Jaroslav Koca,et al.  CAVER: a new tool to explore routes from protein clefts, pockets and cavities , 2006, BMC Bioinformatics.

[69]  Eric F. Johnson,et al.  The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.

[70]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[71]  C. Jarzynski Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.

[72]  K. Palczewski,et al.  Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1* , 2010, The Journal of Biological Chemistry.

[73]  T. Sjögren,et al.  Structural basis for ligand promiscuity in cytochrome P450 3A4 , 2006, Proceedings of the National Academy of Sciences.

[74]  Eric F. Johnson,et al.  Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain , 2008, Proceedings of the National Academy of Sciences.

[75]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[76]  C. Stout,et al.  Structure of the Human Lung Cytochrome P450 2A13* , 2007, Journal of Biological Chemistry.

[77]  Eric F. Johnson,et al.  Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution , 2004, Journal of Biological Chemistry.

[78]  Eric F. Johnson,et al.  Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. , 2010, Journal of molecular biology.

[79]  Alexander Zawaira,et al.  On the deduction and analysis of singlet and two-state gating-models from the static structures of mammalian CYP450. , 2011, Journal of structural biology.